Ara
Toplam kayıt 25, listelenen: 11-20
Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
(Humana Press Inc, 2020)
As we know more about the clinical and laboratory features of COVID-19, which is now accepted as a pandemic, many questions have been raised about how to manage and monitor the treatment of cancer patients. It was determined ...
Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma
(Sage Publications Ltd, 2020)
Introduction Tyrosine kinase inhibitors and immune checkpoint inhibitors are widely used in advanced renal cell carcinoma. Here we reported a left ventricular dysfunction associated with axitinib and nivolumab experience ...
Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG)
(Springer India, 2020)
Marginal zone lymphomas (MZLs) are rare and indolent subtypes of non-Hodgkin lymphomas, and their clinical behaviours are heterogeneous. The aim of this study was to evaluate the clinical and prognostic characteristics of ...
Association of illness perception with chemotherapy-induced nausea and vomiting: a Turkish Oncology Group (TOG) study
(Future Medicine, 2021)
Chemotherapy-induced nausea and vomiting (CINV) may be linked to the psychological status of cancer patients. Therefore, the authors aimed to better understand the underlying risk factors for CINV using the Brief Illness ...
The ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans
(Association of Basic Medical Sciences of FBIH, 2021)
Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue sarcoma that originates from the dermis or subcutaneous tissue in the skin. While its prognosis is generally favorable, disease recurrence is relatively ...
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab
(Springer, 2021)
Background: Atezolizumab (ATZ) has demonstrated antitumor activity and manageable safety in previous studies of patients with metastatic platinum-resistant urothelial carcinoma. However, the response rate of Atezolizumab ...
Attitudes towards and experiences of ethical dilemmas in treatment decision-making process among medical oncologists
(Wiley, 2020)
Aim: This study aimed to evaluate the attitudes towards and experiences of ethical dilemmas in the treatment decision-making process among medical oncologists who are the members of the Turkish Society of Medical Oncology. ...
Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era
(Hospital Clinicas, Univ Sao Paulo, 2020)
The impact of Ki-67 index, squamous differentiation and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer
(Association of Basic Medical Sciences, 2021)
Endometrial endometrioid carcinoma (EEC) represents approximately 75-80% of endometrial carcinoma cases. Three hundred thirty-six patients with EEC followed-up in the authors' institutions between and 2010-2018 were included ...